New Pharma Company Targets Obesity Market Competition
Eli Lilly (NYSE: LLY) is the world's most valuable healthcare stock, valued at over $760 billion, largely due to its ...
Eli Lilly (NYSE: LLY) is the world's most valuable healthcare stock, valued at over $760 billion, largely due to its ...
President Donald Trump announced a 100% tariff on foreign brand-name drugs starting October 1, 2025, raising concerns about potential price ...
US President Donald Trump's announced 100% tariff on branded pharmaceutical imports from Australia, effective October 1, raises concerns about its ...
The president signed an executive action to enhance enforcement against online pharmacies violating FDA regulations on drug advertising, directing the ...
Discover the dynamic market landscape of Veeva Systems (NYSE: VEEV) in the latest episode of the Motley Fool Scoreboard, featuring ...
Chinese biotech stocks are experiencing a significant resurgence, with the Hang Seng Biotech index up 61.8% this year, driven by ...
The Coalition asserts bipartisan support for Australia's Pharmaceutical Benefits Scheme (PBS) amid Donald Trump's proposed 200% tariff on pharmaceutical imports, ...
Investors largely dismissed President Trump's threat of a 200% tariff on pharmaceuticals, viewing it as impractical and part of his ...
SummaryThe CEO of Pfizer has stated that cheaper pharmaceuticals will not be available in the near future, despite an executive ...
SummaryAn English-speaking country once failed economically due to protectionist policies, leading Ireland to embrace foreign investment with low corporate taxes ...
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2025 News Wave
News Wave is not responsible for the content of external sites.